Giant Biogene Holding Co., Ltd.
Research Giant Biogene Holding Co., Ltd. (2367.HK) on Bullrun: market cap HKD 23.99B, P/E 12.9, dividend yield 6.0%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker2367.HK
- ExchangeHK
- CountryChina
- SectorConsumer Defensive
- IndustryHousehold & Personal Products
- CurrencyHKD
- Market capHKD 23.99B
- P/E12.9
- Dividend yield6.0%
- Financial periodFY2025
- RevenueCNY 5.52B
- Revenue growth-0.4%
- Net incomeCNY 1.91B
- Free cash flowCNY 1.35B
- Gross margin80.3%
Valuation Snapshot
latest market cap is HKD 23.99B; P/E is 12.9; dividend yield is 6.0%.
Peer valuation comparison
Latest P/E is 12.91x versus a Consumer Defensive sector median of 16.79x (23.1% below).
Latest dividend yield is 6.04% versus a Consumer Defensive sector median of 2.92% (106.8% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | CNY 5.52B | CNY 1.91B | CNY 1.35B | 80.3% | 1.81 | CNY 6.31B | CNY 9.69M | CNY 9.91B |
| FY2024 | CNY 5.54B | CNY 2.06B | CNY 1.79B | 82.1% | 2.06 | CNY 4.03B | CNY 6.71M | CNY 7.11B |
| FY2023 | CNY 3.52B | CNY 1.45B | CNY 1.42B | 83.6% | 1.48 | CNY 2.50B | CNY 2.73M | CNY 4.36B |
| FY2022 | CNY 2.36B | CNY 1.00B | CNY 778.39M | 84.4% | 0.98 | CNY 1.33B | CNY 2.59M | CNY 2.83B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | HKD 23.99B | 12.9 | 2.7% | 0.62 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0.62 HKD, yield 6.0%.
| Year | Dividends/share |
|---|---|
| FY2025 | 1.31 CNY |
| FY2024 | 0.97 CNY |
About Giant Biogene Holding Co., Ltd.
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It offers functional skincare products, medical dressings and devices, and functional food products under the KOMFYMED, Collgene, Ke Yu, SKIGIN, and other brands. The company also develops and manufactures rare ginsenosides technology-based functional food products.
Related stock research
Other Consumer Defensive stocks
Frequently asked questions
What is Giant Biogene Holding Co., Ltd.'s market cap?
Giant Biogene Holding Co., Ltd.'s market capitalization is HKD 23.99B.
What is Giant Biogene Holding Co., Ltd.'s P/E ratio?
Giant Biogene Holding Co., Ltd.'s price-to-earnings (P/E) ratio is 12.9.
Does Giant Biogene Holding Co., Ltd. pay a dividend?
Giant Biogene Holding Co., Ltd. has a dividend yield of 6.0%.
What does Giant Biogene Holding Co., Ltd. do?
Giant Biogene Holding Co., Ltd., an investment holding company, engages in the research, development, manufacture, and sale of bioactive material-based beauty and health products in the People's Republic of China. It offers functional skincare products, medical dressings and devices, and functional food products under the KOMFYMED, Collgene, Ke Yu, SKIGIN, and other brands. The company also develops and manufactures rare ginsenosides technology-based functional food products. In addition, it provides aesthetic services.